Comprehensive Neurological Nursing and Clinical Concepts Study Guide

Cranial Nerves and Neurological Assessment

• Meninges Definition and Anatomy:

  • The meninges are the fibrous connective tissue layers that cover, protect, and enclose both the brain and the spinal cord.

• Cranial Nerve Classifications and Assessments:

  • Cranial Nerve I (Olfactory Nerve):

  • Assessed by evaluating the client's ability to identify distinct smells or odors.

  • Assessment methods such as utilizing the Snellen chart (visual acuity) or testing pupillary light reflexes do not gauge Cranial Nerve I function.

  • Cranial Nerve V (Trigeminal Nerve):

  • Represented by Roman numeral $V = 5$.

  • Involved in Trigeminal Neuralgia.

  • Affects the sensory portion of the trigeminal nerve.

  • Cranial Nerve VII (Facial Nerve):

  • Represented by Roman numeral $VII = 7$.

  • Cranial Nerve X (Vagus Nerve):

  • Represented by Roman numeral $X = 10$.

  • Cranial Nerve XI (Accessory Nerve):

  • Controls shoulder shrug motor function.

  • Roman Numeral Interpretation Rules:

  • Base Roman numerals include $V = 5$ and $X = 10$.

  • Numerals placed on the right side of a base numeral are added to the base value (e.g., $V + II = VII = 7$).

  • Numerals placed on the left side of a base numeral are subtracted from the base value.

• Glasgow Coma Scale (GCS):

  • Scoring Range: Total GCS scores range from a minimum score of $3$ to a maximum score of $15$.

  • Minimum Score ($3$): Represents the lowest possible score, indicating complete lack of responsiveness with no motor, verbal, or eye-opening response.

  • Maximum Score ($15$): Represents optimal, intact neurological function where the patient opens eyes spontaneously, remains fully oriented, and follows commands.

  • Clinical Scoring Example: A patient who opens eyes or responds to speech, uses inappropriate words, and moves to localize pain receives a score between $3$ and $15$ (score cannot be $0$ or $15$).

• Neuron Pathways and Impulse Transmission:

  • Motor Neurons: Transmit motor impulses away from the Central Nervous System (CNS) out to peripheral muscles and effector organs (e.g., the CNS processes an instruction and sends signals down motor neurons to move a hand).

  • Sensory Neurons: Transmit sensory impulses from peripheral sensory receptors (e.g., skin, hand, nose) inward to the Central Nervous System (CNS) for processing (e.g., touching a hot plate triggers sensory input sent directly to the brain).

Intracranial Pressure (ICP) and Meningeal Pathologies

• Signs and Symptoms of Increased Intracranial Pressure (ICP):

  • Decreased Level of Consciousness (LOC).

  • Pathological posturing (decorticate or decerebrate).

  • High-pitched cry in infants.

  • Vomiting.

  • Bulging fontanels in infants (caused by elevated intracranial fluid pressure; sunken fontanels conversely indicate dehydration).

  • Decreased appetite, irritability, and restlessness (appetite drops; patients do not experience increased appetite).

• Cushing's Triad:

  • A clinical triad signaling significantly elevated intracranial pressure and impending brainstem herniation.

  • Components:

  • Bradycardia (decreased heart rate).

  • Hypertension (elevated blood pressure).

  • Altered/irregular respiratory pattern.

• Meningitis Clinical Assessment:

  • Nuchal Rigidity: Inability to flex the neck forward due to severe neck stiffness.

  • Positive Kernig's Sign: Resistance or pain upon passive extension of the knee when the hip is flexed at a $90^\circ$ angle.

  • Clinical presentation of nuchal rigidity combined with a positive Kernig's sign indicates meningitis.

Pathological Posturing and Brainstem Injury

• Decorticate Posturing:

  • Manifestation: The patient's arms are flexed at the elbow, with hands and wrists pulled inward tightly and raised toward the chest and core of the body.

  • Indicates lesions or damage to the cerebral cortex or corticospinal tracts.

• Decerebrate Posturing:

  • Manifestation: Rigid extensor posturing where extremities are extended straight outward.

  • Indicates severe damage or acute dysfunction occurring at the brainstem level.

Neurological Disorders and Pathophysiology

• Ascending Sensory Neuropathy (Guillain-Barré Progression Pattern):

  • Sensory disturbance characterized by numbness that originates bilaterally in the feet and travels upward along the lower extremities.

• Myasthenia Gravis (MG):

  • Neuromuscular disease caused by a defect or severe lack of the chemical neurotransmitter Acetylcholine at the neuromuscular junction.

• Huntington's Disease:

  • Hereditary neurodegenerative disorder associated with a deficiency/lack of neurotransmitters including Dopamine.

• Amyotrophic Lateral Sclerosis (ALS):

  • Progressive neurodegenerative disease affecting motor neurons, demonstrating structural demyelination patterns similar to multiple sclerosis.

• Cholinergic Crisis:

  • Excessive accumulation of acetylcholine at neuromuscular junctions.

  • SLUDGE Acronym / Diagnostic Symptoms:

  • S: Salivation (profuse drooling).

  • L: Lacrimation (excessive tearing).

  • U: Urination.

  • D: Diarrhea.

  • G: Gastrointestinal cramping/motility.

  • E: Emesis/Hypersecretion from all bodily mucous membranes.

  • Clinical features focus on excessive fluid excretions (diarrhea, urination, lacrimation, salivation); oliguria and constipation are not present.

Pharmacology and Emergency Interventions

• Epinephrine Secretion:

  • Epinephrine (Epi) is produced and secreted by the adrenal glands, located in the back directly on top of each kidney.

• Seizure Management Pharmacotherapy:

  • Active / Acute Seizure Rescue Medications:

  • Fast-acting benzodiazepines administered to terminate an ongoing, active seizure:

    • Lorazepam (Ativan).

    • Diazepam (Valium).

  • Seizure Prevention / Maintenance Medications:

  • Daily anticonvulsant regimens taken long-term for seizure prevention (ineffective as immediate acute rescue agents during an active seizure):

    • Valproic acid.

    • Phenytoin.

    • Phenobarbital.

• Cerebral Edema Management:

  • Diuretics (specifically osmotic diuretics) are administered to reduce tissue fluid accumulation and swelling in the brain.

• Parkinson's Disease Pharmacotherapy:

  • The most effective pharmacological agents for managing Parkinson's disease are Carbidopa and Levodopa.

  • Frequently co-formulated into a single combination medication, although administered individually in certain regimens.

• Thrombolytic Window for Ischemic Stroke:

  • Tissue Plasminogen Activator (tPA) must be initiated within a therapeutic window of $3\text{ to }4\,\text{hours}$ ($3-4\,\text{hours}$) from the exact onset of stroke symptoms.

• Mechanism of Injury (MOI):

  • Trauma caused by a moving blunt object striking the head directly (e.g., getting struck in the head by a baseball) is classified as an acceleration mechanism of injury.